• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995年至2010年法国HIV感染患者的肝脏相关死亡情况:与法国国家艾滋病研究机构(ANRS)合作开展的2010年莫尔塔维克研究及2010年死亡率调查。

Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.

作者信息

Rosenthal E, Roussillon C, Salmon-Céron D, Georget A, Hénard S, Huleux T, Gueit I, Mortier E, Costagliola D, Morlat P, Chêne G, Cacoub P

机构信息

Service de Médecine Interne, Hôpital de l'Archet, CHU de Nice, Nice, France; Université de Nice-Sophia Antipolis, Nice, France.

出版信息

HIV Med. 2015 Apr;16(4):230-9. doi: 10.1111/hiv.12204. Epub 2014 Dec 18.

DOI:10.1111/hiv.12204
PMID:25522874
Abstract

OBJECTIVES

The aim of this study was to describe the proportion of liver-related diseases (LRDs) as a cause of death in HIV-infected patients in France and to compare the results with data from our five previous surveys.

METHODS

In 2010, 24 clinical wards prospectively recorded all deaths occurring in around 26 000 HIV-infected patients who were regularly followed up. Results were compared with those of previous cross-sectional surveys conducted since 1995 using the same design.

RESULTS

Among 230 reported deaths, 46 (20%) were related to AIDS and 30 (13%) to chronic liver diseases. Eighty per cent of patients who died from LRDs had chronic hepatitis C, 16.7% of them being coinfected with hepatitis B virus (HBV). Among patients who died from an LRD, excessive alcohol consumption was reported in 41%. At death, 80% of patients had undetectable HIV viral load and the median CD4 cell count was 349 cells/μL. The proportion of deaths and the mortality rate attributable to LRDs significantly increased between 1995 and 2005 from 1.5% to 16.7% and from 1.2‰ to 2.0‰, respectively, whereas they tended to decrease in 2010 to 13% and 1.1‰, respectively. Among liver-related causes of death, the proportion represented by hepatocellular carcinoma (HCC) dramatically increased from 5% in 1995 to 40% in 2010 (p = 0.019).

CONCLUSIONS

The proportion of LRDs among causes of death in HIV-infected patients seems recently to have reached a plateau after a rapid increase during the decade 1995-2005. LRDs remain a leading cause of death in this population, mainly as a result of hepatitis C virus (HCV) coinfection, HCC representing almost half of liver-related causes of death.

摘要

目的

本研究旨在描述在法国,肝脏相关疾病(LRDs)作为HIV感染患者死因的比例,并将结果与我们之前的五项调查数据进行比较。

方法

2010年,24个临床病房前瞻性记录了约26000名接受定期随访的HIV感染患者中发生的所有死亡情况。将结果与自1995年以来采用相同设计进行的以往横断面调查结果进行比较。

结果

在报告的230例死亡病例中,46例(20%)与艾滋病相关,30例(13%)与慢性肝脏疾病相关。死于LRDs的患者中80%患有慢性丙型肝炎,其中16.7%同时感染乙型肝炎病毒(HBV)。在死于LRD的患者中,41%报告有过量饮酒。死亡时,80%的患者HIV病毒载量检测不到,CD4细胞计数中位数为349个/μL。1995年至2005年期间,LRDs导致的死亡比例和死亡率分别从1.5%显著增加到16.7%,从1.2‰增加到2.0‰,而在2010年它们分别趋于下降至13%和1.1‰。在肝脏相关死因中,肝细胞癌(HCC)所占比例从1995年的5%急剧增加到2010年的40%(p = 0.019)。

结论

在HIV感染患者的死因中,LRDs的比例在1995 - 2005年这十年快速上升后,最近似乎已趋于平稳。LRDs仍然是该人群的主要死因,主要是由于丙型肝炎病毒(HCV)合并感染,HCC几乎占肝脏相关死因的一半。

相似文献

1
Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.1995年至2010年法国HIV感染患者的肝脏相关死亡情况:与法国国家艾滋病研究机构(ANRS)合作开展的2010年莫尔塔维克研究及2010年死亡率调查。
HIV Med. 2015 Apr;16(4):230-9. doi: 10.1111/hiv.12204. Epub 2014 Dec 18.
2
Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).1995 年至 2005 年间法国 GERMIVIC 联合研究组网络(与 Mortalité 2005 调查合作的 Mortavic 2005 研究,ANRS EN19)中与肝脏相关的 HIV 感染者死亡情况。
HIV Med. 2009 May;10(5):282-9. doi: 10.1111/j.1468-1293.2008.00686.x. Epub 2009 Feb 15.
3
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.肝细胞癌在HIV感染患者肝脏相关死因中的新作用:法国2005年全国死亡率研究
J Hepatol. 2009 Apr;50(4):736-45. doi: 10.1016/j.jhep.2008.11.018. Epub 2009 Jan 3.
4
Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.法国慢性乙型肝炎和慢性丙型肝炎相关死亡率:HIV合并感染和饮酒作用的证据
J Hepatol. 2008 Feb;48(2):200-7. doi: 10.1016/j.jhep.2007.09.010. Epub 2007 Nov 20.
5
Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).1995年至2003年期间,法国GERMIVIC联合研究组网络中人类免疫缺陷病毒感染患者的肝脏相关死亡率(MORTAVIC 2003研究)。
J Viral Hepat. 2007 Mar;14(3):183-8. doi: 10.1111/j.1365-2893.2006.00791.x.
6
Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.1995年和1997年法国内科/传染病科中因丙型肝炎病毒导致肝硬化或肝细胞癌的人类免疫缺陷病毒感染患者的死亡率。
Clin Infect Dis. 2001 Apr 15;32(8):1207-14. doi: 10.1086/319747. Epub 2001 Mar 28.
7
Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].人类免疫缺陷病毒(HIV)/丙型肝炎病毒(HCV)合并感染患者的精神障碍和物质使用障碍:HCV清除是否重要?[法国国家艾滋病和病毒性肝炎研究机构(ANRS)HEPAVIH CO13队列研究]
HIV Med. 2016 Nov;17(10):758-765. doi: 10.1111/hiv.12382.
8
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?丙型肝炎病毒血症或基因型是否可预测合并 HIV 感染个体的死亡率风险?
J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11.
9
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.肝外癌症是乙型肝炎病毒控制或丙型肝炎病毒清除患者的主要死亡原因。
Hepatology. 2018 Oct;68(4):1245-1259. doi: 10.1002/hep.30034. Epub 2018 Jul 10.
10
Hepatitis C and hepatitis B-related mortality in Spain.西班牙丙型肝炎和乙型肝炎相关死亡率。
Eur J Gastroenterol Hepatol. 2009 Aug;21(8):895-901. doi: 10.1097/MEG.0b013e328313139d.

引用本文的文献

1
Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data.简短报告:对同时感染HIV-1和乙型肝炎且开始使用比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺或多替拉韦联合恩曲他滨/富马酸替诺福韦二吡呋酯进行治疗的参与者的HIV-1耐药性分析:ALLIANCE数据的亚组分析
J Acquir Immune Defic Syndr. 2024 Aug 1;96(4):380-384. doi: 10.1097/QAI.0000000000003434. Epub 2024 Jun 21.
2
Proinflammatory Biomarkers and Clinical Factors Associated with Long-Term Mortality in People with HIV.与HIV感染者长期死亡率相关的促炎生物标志物和临床因素
Viruses. 2025 Feb 11;17(2):243. doi: 10.3390/v17020243.
3
Risk Factors Associated with Opportunistic Infections among People Living with HIV/AIDS and Receiving an Antiretroviral Therapy in Gabon, Central Africa.中非加蓬接受抗逆转录病毒疗法的艾滋病毒/艾滋病患者发生机会性感染的相关危险因素。
Viruses. 2024 Jan 4;16(1):85. doi: 10.3390/v16010085.
4
Liver Transplantation in People Living with HIV: Still an Experimental Procedure or Standard of Care?HIV感染者的肝移植:仍然是一种实验性手术还是治疗标准?
Life (Basel). 2023 Sep 27;13(10):1975. doi: 10.3390/life13101975.
5
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma.HIV相关肝细胞癌中抗癌免疫反应的综合表型分析
JHEP Rep. 2023 Mar 22;5(7):100741. doi: 10.1016/j.jhepr.2023.100741. eCollection 2023 Jul.
6
A Cross-Sectional Survey on the Post-Pandemic Acceptability of Pharmacist-Delivered Telehealth Services Among HCV-HIV Patients.一项关于 HCV-HIV 患者对药剂师提供的远程医疗服务在大流行后的接受度的横断面调查。
Inquiry. 2023 Jan-Dec;60:469580231171338. doi: 10.1177/00469580231171338.
7
Chronic hepatitis B and HIV coinfection.慢性乙型肝炎与 HIV 合并感染。
Top Antivir Med. 2023 Mar 31;31(1):14-22.
8
Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy.接受侵入性治疗后伴或不伴肝细胞癌复发的HIV感染者的生存情况。
Cancers (Basel). 2023 Mar 8;15(6):1653. doi: 10.3390/cancers15061653.
9
Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV.尼日利亚成人 HIV 感染者和非感染者的肝细胞癌表现和预后。
PLoS One. 2023 Mar 6;18(3):e0282539. doi: 10.1371/journal.pone.0282539. eCollection 2023.
10
Tenofovir use is associated with a decreased risk of hepatocellular carcinoma among men with HIV irrespective of coinfection status.无论是否合并感染,替诺福韦的使用与HIV男性患者肝细胞癌风险降低相关。
JHEP Rep. 2022 Nov 25;5(3):100634. doi: 10.1016/j.jhepr.2022.100634. eCollection 2023 Mar.